Is the 5-HT_1Dβ Receptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder?

Sixty-seven OCD probands were selected. All patients were administered the Structured Clinical Interview for DSM-IV (SCID) and the Yale-Brown Obsessive Compulsive Scale (10). To be eligible for the study, patients had to have either both biological parents or at least one sibling living and willing to participate. The supposedly unaffected siblings were also administered the SCID, and those with any psychiatric disorders were excluded. Patients with a history of neurological or metabolic diseases, bipolar disorder, schizophrenia, or schizoaffective disorder, or with a positive history of substance dependence, were excluded. Written informed consent to participate in the study was obtained from all subjects. Genomic DNA was extracted from whole blood (11), and genotyping of the G861 variant of the gene was performed by means of standard procedures (9).

We tested for the presence of linkage disequilibrium between the 5-HT_1Dβ; receptor gene G861C polymorphism and OCD with the Transmission Disequilibrium Test/sib-Transmission Disequilibrium Test analyses (12). This procedure combines the Transmission Disequilibrium Test, which examines alleles preferentially transmitted from the parents to the affected offspring, with the sib-Transmission Disequilibrium Test, which compares the marker genotypes in affected and unaffected siblings. We specifically tested for excess of transmissions to the affected siblings by using the z test statistic, one-tailed (12).

The proband group included 27 men and 40 women (mean age=33.3 years, SD=8.2; mean age at OCD onset=15.2 years, SD=8.0); there were no significant differences between sexes. The frequency of comorbid tic disorder was 37.3% (N=25). The mean severity of obsessive-compulsive symptoms as measured by score on the Yale-Brown scale was 19.9 (SD=8.7). After genotyping the total study group, 32 families were found suitable for the Transmission Disequilibrium Test/sib-Transmission Disequilibrium Test procedure. Twenty-two were triads that showed heterozygosity at the marker, and 10 were sibships with one affected and one unaffected sibling. The other 35 were families with homozygous parents. The genotype frequencies in the proband group were GG=59.4% (N=19), GC=37.5% (N=12), and CC=3.1% (N=1), while allele frequencies were 78.1% (N=50) and 21.9% (N=14) for the G and the C allele, respectively. The results of the Transmission Disequilibrium Test/sib-Transmission Disequilibrium Test are shown in Table 1.

Our results indicate a significant linkage disequilibrium between the G861C variant of the 5-HT_1Dβ receptor gene and OCD, with preferential transmission of the G allele to the affected subjects. Despite the fact that the silent G861C variant has been claimed to not directly affect the function of the receptor, there are several other possibilities to explain the role of this polymorphism in the pathogenesis of OCD. First, as it has been hypothesized for other serotonin receptor genes (e.g., 5-HT_2A) (13), one of the variants of the G861C polymorphism could induce different mRNA secondary structure, thereby affecting the efficiency of translation. Second, other polymorphisms may exist in the gene that could be in linkage disequilibrium with the G861C variant and be functionally relevant. Further investigations should focus on additional markers in the area and other possible variants of the gene. As seen with other complex disorders, more than one gene is expected to be involved in the etiology of OCD in a model in which each gene per se has a relatively small effect in increasing the risk for the disease. In our case, the estimated increase of risk to develop OCD, as an effect of the presence of the G variant, was equal to 5.26 (Table 1). The possibility that the C variant may play a protective role in the development of OCD is also possible.

The OCD phenotype is heterogeneous, as suggested by the variability in the response to medications in both acute and chronic administrations (2, 14). The investigation of the distribution of this and other 5-HT_1Dβ receptor gene polymorphisms in OCD patients designated as responsive versus nonresponsive to medication will be useful.

Finally, even though it is impossible at this time to define more precisely the role of the 5-HT_1Dβ receptor gene in OCD, the magnitude of the effect that we observed deserves further investigations. Only a combined strategy, which implies an exhaustive exploration of the OCD phenotype and a more extended knowledge of the genetic complexity of the 5-HT_1Dβ gene, will be able to shed light on this potential component of the etiology of OCD.

Received June 23, 1999; revision received Nov. 24, 1999; accepted Jan. 27, 2000. From the Neurogenetics Section and the Anxiety Disorders Clinic of the Centre for Addiction and Mental Health, University of Toronto. Address reprint requests to Dr. Kennedy, Neurogenetics Section, Centre for Addiction and Mental Health, 250 College St., Toronto, Ont., Canada, M5T 1R8. Supported in part by a grant from the Ontario Mental Health Foundation.